These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1869457)

  • 1. Second neoplasms in patients with carcinomas of the vocal cord: incidence and implications for survival.
    Roberts TJ; Epstein B; Lee DJ
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):583-9. PubMed ID: 1869457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second malignant neoplasia in patients with T1 glottic cancer treated with radiation.
    Fujita M; Rudoltz MS; Canady DJ; Patel P; Machtay M; Pittard MQ; Mohiuddin M; Regine WF
    Laryngoscope; 1998 Dec; 108(12):1853-5. PubMed ID: 9851503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
    Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
    J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metachronous second primary cancers after successful partial laryngectomy for invasive squamous cell carcinoma of the true vocal cord.
    Laccourreye O; Veivers FD; Hans S; Brasnu FD; Garcia D; Laccourreye FL
    Ann Otol Rhinol Laryngol; 2002 Mar; 111(3 Pt 1):204-9. PubMed ID: 11913679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignant neoplasms in patients with head and neck squamous cell carcinomas.
    Boysen M; Loven JO
    Acta Oncol; 1993; 32(3):283-8. PubMed ID: 8323766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple primary malignant neoplasm in patients with laryngeal carcinoma.
    Esposito ED; Bevilacqua L; Guadagno MT
    J Surg Oncol; 2000 May; 74(1):83-6. PubMed ID: 10861616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
    Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
    Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx.
    Gorphe P; Blanchard P; Breuskin I; Temam S; Tao Y; Janot F
    J Laryngol Otol; 2015 Sep; 129(9):903-9. PubMed ID: 26201253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?
    Fein DA; Lee WR; Hanlon AL; Ridge JA; Curran WJ; Coia LR
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):823-31. PubMed ID: 8598359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diode laser microsurgery for treatment of Tis and T1 glottic carcinomas.
    Ferri E; Armato E
    Am J Otolaryngol; 2008; 29(2):101-5. PubMed ID: 18314020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1 glottic carcinoma involving the posterior commissure.
    Shvero J; Shvili I; Mizrachi A; Shpitzer T; Nageris B; Koren R; Hadar T
    Laryngoscope; 2009 Jun; 119(6):1116-9. PubMed ID: 19308987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A large French multicenter retrospective series of T1-T2N0 vocal cords carcinomas treated with exclusive irradiation.
    Robert A; Pointreau Y; Janoray G; Bardet É; Fesneau M; Garaud P; Chapet S; Lafond C; Dupuis O; Calais G
    Cancer Radiother; 2017 Jun; 21(4):286-290. PubMed ID: 28522278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
    Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary respiratory tract malignancies in glottic carcinoma.
    Wagenfeld DJ; Harwood AR; Bryce DP; van Nostrand AW; DeBoer G
    Cancer; 1980 Oct; 46(8):1883-6. PubMed ID: 7427891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T3 and T4 true vocal cord squamous carcinomas treated with external beam irradiation: a single institution's 35-year experience.
    Hinerman RW; Mendenhall WM; Morris CG; Amdur RJ; Werning JW; Villaret DB
    Am J Clin Oncol; 2007 Apr; 30(2):181-5. PubMed ID: 17414468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
    Yücetürk AV; Celik O; Eskiizmir G
    Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
    Laccourreye O; Weinstein G; Brasnu D; Bassot V; Cauchois R; Jouffre V; Garcia D; Laccourreye H
    Cancer; 1994 Nov; 74(10):2781-90. PubMed ID: 7954237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.